KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Illumina (ILMN) EBT (2016 - 2025)

Illumina's EBT history spans 17 years, with the latest figure at $377.0 million for Q4 2025.

  • For Q4 2025, EBT rose 101.6% year-over-year to $377.0 million; the TTM value through Dec 2025 reached $1.1 billion, up 192.11%, while the annual FY2025 figure was $1.1 billion, 192.11% up from the prior year.
  • EBT reached $377.0 million in Q4 2025 per ILMN's latest filing, up from $220.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $720.0 million in Q3 2024 to a low of -$5.1 billion in Q1 2023.
  • Average EBT over 5 years is -$470.8 million, with a median of $154.5 million recorded in 2021.
  • Peak YoY movement for EBT: crashed 2120.22% in 2024, then surged 266.97% in 2025.
  • A 5-year view of EBT shows it stood at $420.0 million in 2021, then tumbled by 974.29% to -$3.7 billion in 2022, then soared by 95.45% to -$167.0 million in 2023, then skyrocketed by 211.98% to $187.0 million in 2024, then soared by 101.6% to $377.0 million in 2025.
  • Per Business Quant, the three most recent readings for ILMN's EBT are $377.0 million (Q4 2025), $220.0 million (Q3 2025), and $306.0 million (Q2 2025).